Shopping Cart
Remove All
Your shopping cart is currently empty
BRD4 Inhibitor-15 (compound 13) is a highly potent and specific BRD4 inhibitor with an IC50 of 18 nM, inducing apoptosis in 22RV1 cells by regulating Bcl-2/Bax proteins and activating caspase-3 signaling, and down-regulating c-Myc levels, making it valuable for prostate cancer research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,140 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $2,785 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $3,520 | 6-8 weeks | 6-8 weeks |
| Description | BRD4 Inhibitor-15 (compound 13) is a highly potent and specific BRD4 inhibitor with an IC50 of 18 nM, inducing apoptosis in 22RV1 cells by regulating Bcl-2/Bax proteins and activating caspase-3 signaling, and down-regulating c-Myc levels, making it valuable for prostate cancer research [1]. |
| Targets&IC50 | BRD4(1):18 ± 1.1 nM |
| In vitro | BRD4 Inhibitor-15 (also known as compound 13) demonstrates significant anti-proliferative effects on both enzalutamide-resistant 22RV1 cells and LNCap cells. Specifically, it exhibits half-maximal inhibitory concentration (IC50) values of 8.27 ± 0.28 μM and 7.33 ± 0.49 μM for each cell line, respectively [1]. |
| Molecular Weight | 359.42 |
| Formula | C22H21N3O2 |
| Cas No. | 2761366-60-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.